TrialHeadache2021

Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study.

Richard B Lipton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.